Join the search for a potential new cancer therapy!

Do you have cancer with a MET alteration?

Learn about an investigational drug designed to target the c-Met pathway and slow tumor growth in the SPARTA study. If you have non-small cell lung cancer (NSCLC), brain cancer, or another advanced solid tumor, you may qualify.

Learn More Do I Qualify?
Copyright © 2020   |  SPARTA Study  |   All Rights Reserved   |  Privacy    |  Terms & Conditions